|Articles|September 1, 2011
- BioPharm International-09-02-2011
- Volume 2011 Supplement
- Issue 6
BioPharm International, September 2011 Supplement (PDF)
Biopharmaceutical Trends Report
Advertisement
Articles in this issue
over 14 years ago
Q&A with Francis S. Collinsover 14 years ago
Single-use Technology: Balancing the Risks and Rewardsover 14 years ago
Challenges and Innovations with Prefilled Syringesover 14 years ago
Trends in Prefillsover 14 years ago
Perception and Costs of Biotech Innovationover 14 years ago
Navigating the Biosimilars MarketNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5